17-63910802-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022579.3(CSHL1):āc.133C>Gā(p.Arg45Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000563 in 1,614,216 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022579.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSHL1 | NM_022579.3 | c.133C>G | p.Arg45Gly | missense_variant | 2/5 | ENST00000309894.6 | NP_072101.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSHL1 | ENST00000309894.6 | c.133C>G | p.Arg45Gly | missense_variant | 2/5 | 5 | NM_022579.3 | ENSP00000309524 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000545 AC: 83AN: 152210Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000847 AC: 213AN: 251438Hom.: 1 AF XY: 0.000868 AC XY: 118AN XY: 135896
GnomAD4 exome AF: 0.000565 AC: 826AN: 1461888Hom.: 2 Cov.: 34 AF XY: 0.000590 AC XY: 429AN XY: 727246
GnomAD4 genome AF: 0.000545 AC: 83AN: 152328Hom.: 1 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2022 | The c.133C>G (p.R45G) alteration is located in exon 2 (coding exon 2) of the CSHL1 gene. This alteration results from a C to G substitution at nucleotide position 133, causing the arginine (R) at amino acid position 45 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at